APA (7th ed.) Citation

KC, C., MH, C., CN, L., CH, C., JF, W., YH, N., . . . HL, C. (2019). Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers. Alimentary pharmacology & therapeutics, 50(3), 306. https://doi.org/10.1111/apt.15321

Chicago Style (17th ed.) Citation

KC, Chang, et al. "Decreased Neonatal Hepatitis B Virus (HBV) Viremia by Maternal Tenofovir Treatment Predicts Reduced Chronic HBV Infection in Children Born to Highly Viremic Mothers." Alimentary Pharmacology & Therapeutics 50, no. 3 (2019): 306. https://doi.org/10.1111/apt.15321.

MLA (9th ed.) Citation

KC, Chang, et al. "Decreased Neonatal Hepatitis B Virus (HBV) Viremia by Maternal Tenofovir Treatment Predicts Reduced Chronic HBV Infection in Children Born to Highly Viremic Mothers." Alimentary Pharmacology & Therapeutics, vol. 50, no. 3, 2019, p. 306, https://doi.org/10.1111/apt.15321.